Potential new use for apixaban: A trial of 28 days of low dose apixaban vs enoxaparin for Thromboprophylaxis in Women Undergoing Surgery for Gynecologic Malignant Neoplasm shows no difference in VTE rates or bleeding https://t.co/mtbtJhznBU
RT @MarcCarrier1: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/0XNqNto…
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
RT @MarcCarrier1: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/0XNqNto…
Awesome, that makes life easier!
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
RT @MarcCarrier1: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/0XNqNto…
RT @RobertoVargasMD: Apixaban instead of LMWH for DVT/PE prophy after gyn onc surgery? Yes please. No more lovenox teaching on day of di…
RT @MarcCarrier1: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/0XNqNto…
RT @MarcCarrier1: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/0XNqNto…
RT @MarcCarrier1: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/0XNqNto…
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
RT @RossFH: In RCT comparing apixaban to LWMH as prophylaxis after gyn. cancer surgery, apixaban was found to be safe and associated with g…
RT @MarcCarrier1: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/0XNqNto…
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
RT @MarcCarrier1: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/0XNqNto…
RT @MarcCarrier1: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/0XNqNto…
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
Apixaban strikes again!
RT @MarcCarrier1: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/0XNqNto…
Apixaban instead of LMWH for DVT/PE prophy after gyn onc surgery? Yes please. No more lovenox teaching on day of discharge to hold everything up! @RobDeBernardo @ChadMichenerMD @LAURAJMOULTON @m_kuznicki
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/3k49dddaB1
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
RT @MarcCarrier1: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/0XNqNto…
RT @OncoCard_Ganken: #Apixaban vs #Enoxaparin for #Preventing #PostoperativeThromboembolism in Women With #GynecologicCancer https://t.co…
#Apixaban vs #Enoxaparin for #Preventing #PostoperativeThromboembolism in Women With #GynecologicCancer https://t.co/l5C5M9bMRx 👉oral apixaban may offer a safe alternative to subcutaneous enoxaparin that is easier and less painful for pts to take. 痛く無
Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/0XNqNtou9G
One of the most common qs I get re #VTE prophylaxis is whether safe to use DOACs in post op setting. However, until this paper minimal data available (1/n, I have #FCOI) https://t.co/wiXE5kxkdX
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
RT @womenofteal: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/Nn2J6ifB…
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
RT @DrAhmedAlShehri: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer: — Apixaban has s…
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer: — Apixaban has similar prevention against #VTE within 60 days and similar bleeding risk within 30 days to Enoxaparin. @JAMA_current https://t.co/yHQzXj8YS
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
Evidence keeps adding up for DOACs. 👍
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
RT @JAMA_current: Published in @JAMANetworkOpen
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
RT @juanjolopezn: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_…
RT @JAMA_current: Published in @JAMANetworkOpen https://t.co/wQVvOPlgIA
Published in @JAMANetworkOpen
RT @womenofteal: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/Nn2J6ifB…
Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer #VTE # cancer @JAMA_current https://t.co/amS6UdzfWY
#SeguridadyEficacia de #Apixaban versus #enoxaparina para #PrevenirTromboembolismo venoso postoperatorio en mujeres sometidas a cirugía por #Neoplasia maligna ginecológica De @JAMANetworkOpen Compartido por @womenofteal https://t.co/kENR83eORZ
RT @RossFH: In RCT comparing apixaban to LWMH as prophylaxis after gyn. cancer surgery, apixaban was found to be safe and associated with g…
RT @seda2211: Good option for patients..#gynonc #oncoalert https://t.co/qwQhzqwmdZ
RT @RossFH: In RCT comparing apixaban to LWMH as prophylaxis after gyn. cancer surgery, apixaban was found to be safe and associated with g…
Good option for patients..#gynonc #oncoalert
RT @RossFH: In RCT comparing apixaban to LWMH as prophylaxis after gyn. cancer surgery, apixaban was found to be safe and associated with g…
RT @RossFH: In RCT comparing apixaban to LWMH as prophylaxis after gyn. cancer surgery, apixaban was found to be safe and associated with g…
RT @womenofteal: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/Nn2J6ifB…
RT @womenofteal: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/Nn2J6ifB…
😍 Thanks Dr Guntupalli et al! https://t.co/0HbW6JG5XW
RT @RossFH: In RCT comparing apixaban to LWMH as prophylaxis after gyn. cancer surgery, apixaban was found to be safe and associated with g…
RT @RossFH: In RCT comparing apixaban to LWMH as prophylaxis after gyn. cancer surgery, apixaban was found to be safe and associated with g…
RT @womenofteal: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/Nn2J6ifB…
RT @womenofteal: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/Nn2J6ifB…
RT @RossFH: In RCT comparing apixaban to LWMH as prophylaxis after gyn. cancer surgery, apixaban was found to be safe and associated with g…
Not licensed for #Gynaeonc procedures @NHSuk however #evidence for consideration @NICEComms . Improved #patientcompliance likely! #thromboprophylaxis #DVT #patientsafety #PatientCare #patientaccess
In RCT comparing apixaban to LWMH as prophylaxis after gyn. cancer surgery, apixaban was found to be safe and associated with greater patient satisfaction and less pain. #gyncsm #oncsurgery #gynonc @JAMANetworkOpen https://t.co/aCxVO9BlXj https://t.co/DFyg
RT @womenofteal: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/Nn2J6ifB…
RT @womenofteal: Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/Nn2J6ifB…
Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/Nn2J6ifBlq #gyncsm #OncoAlert oral apixaban is potentially safe, less painful, easier-to-take alternative to subcutaneous enoxaparin for throm
RT @rincondesisifo: (JAMA) Apixabán vs enoxaparina en la prevención del TEV postquirúrgico en pac con tumores ginecológicos https://t.co/pk…
(JAMA) Apixabán vs enoxaparina en la prevención del TEV postquirúrgico en pac con tumores ginecológicos https://t.co/pkcObNYCPi ECA https://t.co/sxMlOnMeKC Comentario https://t.co/285pIpj3Iw
RT @cupallcare: New Oral anticoagulants often used in Cancer patients. The evidence begins to build that this is a good idea @cupallcare @c…
RT @drkpavithran: Apixaban is a safe alternative to enoxaparin for thromboprophylaxis after surgery for gynecologic cancer. No increased ri…
Apixaban is a safe alternative to enoxaparin for thromboprophylaxis after surgery for gynecologic cancer. No increased risk of bleeing https://t.co/0R2wzN6kUy
RT @DharaniNaren: Well written, way to go Saketh Guntupalli! https://t.co/WCKujlElRU
Well written, way to go Saketh Guntupalli! https://t.co/WCKujlElRU
New Oral anticoagulants often used in Cancer patients. The evidence begins to build that this is a good idea @cupallcare @cuonline @cuanschutz Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co
Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/Iinf96acoI
RT @JAMANetworkOpen: RCT finds oral apixaban is a potentially safe alternative to subcutaneous enoxaparin for thromboprophylaxis following…
RT @JAMANetworkOpen: RCT finds oral apixaban is a potentially safe alternative to subcutaneous enoxaparin for thromboprophylaxis following…
Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: A Randomized Clinical Trial | Oncology | JAMA Network Open | JAMA Network @PeterMacCC https
Former #student and #research #mentee of mine published in @JAMANetworkOpen. Congrats Alyse! Way to go!
Apixaban vs Enoxaparin for Preventing Postoperative Thromboembolism in Women With Gynecologic Cancer https://t.co/Xty30R12qy 低用量アピキサバン!
RCT finds oral apixaban is a potentially safe alternative to subcutaneous enoxaparin for thromboprophylaxis following gynecologic surgery for cancer. #VisualAbstract https://t.co/VAWS9SUaGn